Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ·Healthcare·Biotechnology
$11.41
-1.55%
Mkt Cap $958.19M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $57.17M | $57.58M | +0.72% | -$0.32 | -$0.16 | +49.90% | — | — |
| Q4 2025 Oct 30, 2025 | $57.44M | $49.50M | -13.82% | -$0.30 | -$0.15 | +50.00% | — | — |
| Q3 2025 Aug 7, 2025 | $46.77M | $39.50M | -15.55% | -$0.76 | -$0.79 | -3.95% | — | — |
| Q2 2025 May 1, 2025 | $35.65M | $28.52M | -19.99% | -$1.06 | -$1.07 | -0.94% | — | — |
| Q1 2025 Mar 6, 2025 | $29.04M | $29.66M | +2.15% | -$1.29 | -$0.79 | +38.76% | — | — |
| Q4 2024 Nov 7, 2024 | $25.77M | $16.35M | -36.55% | -$1.57 | -$1.32 | +15.92% | — | — |
| Q3 2024 Aug 8, 2024 | $5.81M | $7.32M | +26.06% | -$1.20 | -$1.25 | -4.17% | — | — |
| Q2 2024 May 9, 2024 | $2.05M | $1.91M | -6.73% | -$1.43 | -$1.42 | +0.70% | — | — |
| Q1 2024 Mar 7, 2024 | $410.00K | $682.00K | +66.34% | -$0.92 | -$0.80 | +13.04% | — | — |
| Q4 2023 Nov 9, 2023 | $800.00K | — | — | -$0.95 | -$0.76 | +20.00% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.95 | -$0.84 | +11.58% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$1.34 | -$0.89 | +33.58% | — | — |
| Q1 2023 Feb 28, 2023 | $200.00K | — | — | -$1.50 | -$1.33 | +11.33% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$1.32 | -$1.32 | +0.00% | — | — |
| Q3 2022 Aug 2, 2022 | — | — | — | -$1.03 | -$1.33 | -29.13% | — | — |
| Q2 2022 May 10, 2022 | $211.00K | — | — | -$0.97 | -$1.07 | -10.31% | — | — |
| Q1 2022 Mar 1, 2022 | — | — | — | -$0.86 | -$0.95 | -10.47% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.78 | -$0.98 | -25.64% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$1.07 | -$1.00 | +6.54% | — | — |
| Q2 2021 May 11, 2021 | — | — | — | -$1.11 | -$0.96 | +13.51% | — | — |